0001213900-19-025247.txt : 20191203
0001213900-19-025247.hdr.sgml : 20191203
20191203194106
ACCESSION NUMBER: 0001213900-19-025247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191129
FILED AS OF DATE: 20191203
DATE AS OF CHANGE: 20191203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCAMBOLI STEPHEN
CENTRAL INDEX KEY: 0001221451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 191267005
MAIL ADDRESS:
STREET 1: C/OPARMOUNT CAPITAL
STREET 2: 787 SEVENTH AVE 48TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2019-11-29
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001221451
ROCAMBOLI STEPHEN
2600 VIA FORTUNA, SUITE 360
AUSTIN
TX
78746
1
0
0
0
Stock Options (Right to Buy)
5.00
2019-11-29
4
A
0
3623
0.00
A
2029-10-29
Common Stock
3623
139429
D
25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
/s/ Stephen C. Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
2019-12-03